The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in Australia
Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.1285
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2013
Authors
Publisher
Elsevier BV